Tresu Investment Holding A/S
24.3.2026 08:59:54 CET | Globenewswire | Press release
TRESU Investment Holding A/S – Settlement of interest payment by issuance of interest bonds
TRESU Investment Holding A/S – Settlement of interest payment by issuance of interest bonds
TRESU INVESTMENT HOLDING A/S
ANNOUNCEMENT NO. 01.2026
24.03.2026
TRESU Investment Holding A/S – Settlement of interest payment by issuance of interest bonds
Capitalised terms used but not defined are used with the meanings given to them in the Terms and Conditions (as defined below).
TRESU Investment Holding A/S gives notice to the holders of its Senior Secured Floating Rate Bonds 2017/2027 with ISIN no. DK0030404967 (the “Bonds”) issued pursuant to the terms and conditions originally dated 22 September 2017 as last amended and restated on 22 December 2023 (the "Terms and Conditions") that the Interest Payment Test has not been met in respect of the Interest Payment Date on 31 March 2026 and that it will settle the payment of Interest that should have been made on 31 March 2026 by issuance of Interest Bonds in accordance with Clause 8(b) of the Terms and Conditions.
Any questions can be directed to:
Jesper Eriksen
Chief Financial Officer, TRESU
Phone: +45 6073 1967
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S25.10.2026 12:00:00 CET | Press release
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
Orion Oyj24.10.2026 08:35:00 CEST | Press release
Darolutamide plus ADT and radiation therapy reduces risk of metastasis or death by 58% in prostate cancer patients at high risk of recurrence
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom